10 results about "Manuka Honey" patented technology

Medicinal and nutraceutical formulations based on Chaga mushrooms, chemical compounds and pharmaceutical compositions, and methods of production. When administered to a human or animal, the formulations, compounds, and pharmaceutical compositions are useful for the treatment of diseases such as cancers. The nutraceutical formulation includes a reduction of Chaga mushroom, where the reduction is formed in a reduction solvent; and an extraction of Chaga mushroom, where the extraction is formed in an extraction solvent. The reduction and extraction are mixed together or combined in accordance with methods known to those skilled in the art, to form the nutraceutical formulation. The medicinal formulation is a reaction product made by preparing a Chaga mushroom reduction in a reduction solvent under pressure, preparing a Chaga mushroom extraction in an extraction solvent, mixing or combining the Chaga reduction with the Chaga extraction, mixing or combining the Chaga formulation with an esterification mixture containing proline, fructose, and a fatty acid for the development of esterified compounds, and including sources of sugar esters capable of emulsion within otherwise non-miscible liquid compounds, or a predetermined amount of Manuka honey sufficient to cause esterification and facilitate emulsion at a temperature capable of inducing a reaction between the constituents of the Chaga mushroom with the constituents of the esterification mixture or Manuka honey, and combining that heterogenous mixture with medium chain triglyceride oil.

Disclosed are equine supplement compositions for enhancing the health and well-being of horses. For instance, a composition may include a first portion containing one or more components selected from slippery elm, milk thistle, spirulina, marshmallow root, licorice root, alfalfa leaf, and ashwaganda; and a second portion containing one or more components selected from lysine, MSM, and goji berry. Additionally, a second composition may include an oil component selected from flax seed oil and coconut oil, combined with a honey component comprising manuka honey. Furthermore, a third composition may include a vitamin E component and a selenium component. The supplemental compositions provides a novel, cost-effective, simple, effective, efficient, and sustainable solution for supporting the overall health, performance, and longevity of horses by providing essential nutrients and beneficial compounds that target various aspects of equine health.

The invention relates to a nutritional supplement in form of a tea beverage which provides health and longevity benefits when consumed. The main composition of the invention includes carob, anise, eucalyptus and thyme. The composition may further include honey and micellized curcumin. The tea beverage may also contain other compositions such as green tea, manuka honey and similar natural herbs and ingredients with health benefits. The forms for this tea beverage composition include, without limitation, tea bags, loose-leaf tea (also sometimes referred to as loose or powdered tea), ready-to-drink beverages and tea in powder (or micronized powder) form.

Cosmetic care composition for topical application to sensitive and inflamed skin, in particular for the relief of psoriasis symptoms or atopic dermatitis symptoms, comprising in weight percent: Manuka honey with a defined UMF ≥15+ or MGO ≥540 mg / kg in a concentration of at least 4% in combination with Aloe Vera juice concentrate in a concentration of at least 0.1%, Panthenol in a concentration of at least 3.0%, squalane in a concentration of at least 6.0%, Shea butter in a concentration of at least 4.0%, and hyaluronic acid in a concentration of at least 0.02%, at least one natural emulsifier and humectant, and a preservation system, and where the rest is water ad 100%.

Medical preparations and functional food preparations, compounds, and pharmaceutical compositions based on Chaga, as well as methods for their manufacture. When administered to humans or animals, the preparations, compounds, and pharmaceutical compositions are useful for treating diseases such as cancer. Functional food preparations include a reduced product of Chaga formed in a reducing solvent and an extract of Chaga formed in an extracting solvent. The reduced product and the extract are mixed or combined according to methods known to those skilled in the art to form functional food preparations. The medical formulations are reaction products produced by preparing a reduced Chaga product in a pressurized reducing solvent, preparing a Chaga extract in an extraction solvent, mixing or combining the reduced Chaga product with the Chaga extract, mixing or combining the Chaga formulation with an esterification mixture containing proline, fructose, and fatty acids for generating esterification compounds and a source of sugar esters that can be emulsified in otherwise immiscible liquid compounds, or with a predetermined amount of Manuka honey sufficient to bring about esterification and promote emulsification, at a temperature that can induce a reaction between the components of Chaga and the esterification mixture or Manuka honey, and combining the heterogeneous mixture with medium-chain triglyceride oil.

The invention relates to the technical field of pharmaceutical compositions, in particular to a pharmaceutical composition for synergistically inhibiting klebsiella pneumoniae and infectious pneumonia of the klebsiella pneumoniae, a preparation and application, and the composition is prepared from the following components in parts by weight: 50-200 parts of berberine, 10-100 parts of andrographolide, 10-100 parts of manuka honey and 10-50 parts of polymyxin B. In-vitro antibacterial study is carried out on the berberine, the andrographolide, the manuka honey and the polymyxin B, and it is found that the andrographolide, the berberine and the manuka honey can all improve the antibacterial effect of the polymyxin B and all generate a synergistic effect when being combined for use; besides, the combination of the four medicines provided by the invention is used for treating a mouse suffering from Klebsiella pneumonia infectious severe pneumonia, the effect of the combination of the four medicines is obviously superior to that of a single medicine, and the effect of treating the Klebsiella pneumonia infectious severe pneumonia can be obviously improved after the medicine composition provided by the invention is compounded.

The invention relates to plant beverage preparation, in particular to a compound turmeric plant beverage and a preparation method thereof.The method comprises the following steps that firstly, a turmeric raw material is fed into a crushing section through a feeding section to be crushed; 2, the crushed turmeric raw material enters an extraction section to be extracted, and turmeric liquid and turmeric residues are separated; the invention relates to a compound turmeric plant beverage. The radix curcumae longae is 1,000 mg to 1,200 mg; 5 mg to 7 mg of a black pepper extract; 20 to 24 g of concentrated apple clear juice; 10 to 15 g of manuka honey; 300 mg to 340 mg of white tricholoma matsutake freeze-dried powder; 50 mg to 60 mg of vitamin C; 200 mg to 240 mg of concentrated pleurotus citrinopileatus powder; the content of glycine betaine is 500 mg to 550 mg; 100 mg to 140 mg of ground cinnamon; the volume of the water ranges from 500 mL to 550 mL. The problems of low extraction rate and system incoherence in the prior art are solved.

This invention provides a natural wound ointment dressing to address the problem of applying natural ingredients to the treatment of pressure sores, diabetic ulcers, and burn wounds; the natural wound ointment dressing is composed of the following natural ingredients: curcumin, Manuka honey, tea tree oil, and aloe vera gel.

Provided is a formulation useful for treating sore throat, throaty cough, xerostomia, pharyngitis, laryngitis, postoperative pain, dysphagia, laryngeal granuloma, vocal optimization, laryngopharyngeal reflux or dysbiosis, wherein the formulation comprises: an aqueous solution comprising one or more active ingredients selected from the group consisting of marshmallow root, slippery elm extract, aloe vera extract, manuka honey, honey, holy basil, menthol, spearmint, capsaicin, propolis, curcumin, xylitol, turmeric, probiotics, and calendula, the aqueous solution being present as aerosolized particles in a range of 10 to 35 microns.

A reactivatable wound dressing composition comprising a dehydrated bacterial cellulose matrix derived from kombucha fermentation of organic green tea and Manuka honey. The matrix contains embedded dormant colonies of acetic acid bacteria, residual epigallocatechin gallate from green tea, and methylglyoxal from Manuka honey. The dormant bacterial colonies reactivate upon contact with an aqueous kombucha solution, providing antimicrobial activity against pathogens including Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The dehydrated matrix exhibits natural adhesive properties upon rehydration without requiring additional adhesives. Manufacturing methods involve controlled fermentation at specific pH and temperature parameters, followed by dehydration to preserve bacterial viability. The dressing maintains optimal wound environments by retaining moisture while allowing oxygen exchange, stimulates tissue regeneration, and can be die-cut into various anatomical shapes. Applications include treatment of cuts, burns, surgical incisions, chronic wounds, and skin ulcers with extended wear times of 5-10 hours.